undamentalytics Newsletter

Shoulder Innovations, Inc. income statement

In fiscal 2025, Shoulder Innovations, Inc. reported revenue of $47.3m, up 49.6% on the year before, operating income of −$26.3m (a -55.6% margin) and net income of −$40.4m, or −$4.65 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Shoulder Innovations, Inc.: income statement, annual
Fiscal year2024Dec 20242025Dec 2025LTMJun 2026
Revenue324760
Cost of revenue71114
Gross profit243646
Research and development4812
Selling, general and administrative355570
Operating income−15−26−35
Interest expense10−2
Income before tax−16−40−35
Income tax000
Net income−16−40−35
Diluted EPS−$242.04−$4.65—
Diluted shares (average)—9m—
EBITDA−13−23−31

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: LNSR vs SICVRX vs SIAPYX vs SI

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Shoulder Innovations, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Shoulder Innovations, Inc.